The Gross Margin of GenMont Biotech Inc (3164.TW) is 61.80%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 61.80% |
| 2023-12-31 | 66.41% |
| 2022-12-31 | 69.66% |
| 2021-12-31 | 69.95% |
| 2020-12-31 | 66.23% |
| 2019-12-31 | 66.34% |
| 2018-12-31 | 68.27% |
| 2017-12-31 | 69.51% |
| 2016-12-31 | 57.34% |
| 2015-12-31 | 51.11% |